A QXP-based multistep docking procedure for accurate prediction of protein-ligand complexes

Journal of Chemical Information and Modeling

Volumn 46, Issue 3, 2006, Pages 1174-1187

  Alisaraie, Laleh ^a   Haller, Lars A ^a   Fels, Gregor ^a  

^a UNIVERSITY OF PADERBORN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONS; DEGREES OF FREEDOM (MECHANICS); ENZYME INHIBITION; MOLECULAR STRUCTURE; MONTE CARLO METHODS; PROTEINS;

ACETYLCHOLINESTERASE INHIBITOR; CONFORMATIONAL SEARCH SPACE; PROTEIN BINDING SITE; TORSIONAL FLEXIBILITY;

DOCKING;

LIGAND; PROTEIN;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; METABOLISM; MONTE CARLO METHOD;

BINDING SITES; LIGANDS; MODELS, MOLECULAR; MONTE CARLO METHOD; PROTEINS;

EID: 33745390664     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050343m     Document Type: Article

References (53)

1. Muegge, I.; Rarey, M. Small Molecule Docking and Scoring. Rev. Comput. Chem. 2001, 17, 1-60.
2. Kitchen, D. B.; Decornez, H.; Furr, J. R.; Bajorath, J. Docking and Scoring in Virtual Screening for Drug Discovery: Methods and Applications. Nat. Rev. Drug Discovery 2004, 3, 935-949.
3. Mohan, V.; Gibbs, A. C.; Cummings, M. D.; Jaeger, E. P.; DesJarlais, R. L. Docking: Successes and Challenges. Curr. Pharm. Des. 2005, 11, 323-333.
4. Congreve, M.; Murray, C. W.; Blundell, T. L. Structural Biology and Drug Discovery. Drug Discovery Today 2005, 10, 895-907.
5. Wolfson, H. J.; Shatsky, M.; Schneidman-Duhovny, D.; Dror, O.; Shulman-Peleg, A.; Ma, B. Y.; Nussinov, R. From Structure to Function: Methods and Applications. Curr. Protein Pept. Sci. 2005, 6, 171-183.
6. Abagyan, R.; Totrov, M. High-Throughput Docking for Lead Generation. Curr. Opin. Chem. Biol. 2001, 4, 375-382.
7. Halperin, I.; Ma, B.; Wolfson, H.; Nussinov, R. Principles of Docking: An Overview of Search Algorithms and a Guide to Scoring Functions. Proteins 2002, 47, 409-443.
8. Krovat, E. M.; Steindl, T.: Langer, T. Recent Advances in Docking and Scoring. Curr. Comput.-Aided Drug Des. 2005, 1, 93-102.
9. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Boume, P. E. The Protein Data Bank [http://www.rcsb.org/pdb/]. Nucleic Acids Res. 2000, 28, 235-242.
10. Kroemer, R. T.; Vulpetti, A.; McDonald, J. J.; Rohrer, D. C.; Trosset, Y.; Giordanetto, F.; Cotesta, S.; McMartin, C.; Kihlen, M.; Stouten, P. F. W. Assessment of Docking Poses: Interactions-Based Accuracy Classification (IBAC) versus Crystal Structures Deviations. J. Chem. Inf. Comput. Sci. 2004, 44, 871-881.
11. Davis, A. M.; Teague, S. J.; Kleywegt, G. J. Applications and Limitations of X-ray Crystallographic Data in Structure-Based Ligand and Drug Design. Angew. Chem., Int. Ed. 2003, 42, 2718-2736.
12. Tame, J. R. H. Scoring Functions: A View from the Bench. J. Comput.-Aided Mol. Des. 1999, 13, 99-108.
13. Toledo-Sherman, L. M. High-Throughput Virtual Screening for Drug Discovery in Parallel. Curr. Opin. Drug Discovery Dev. 2002, 5, 414-421.
14. Waszkowycz, B. Structure-Based Approaches to Drug Design and Virtual Screening. Curr. Opin. Drug Discovery Dev. 2002, 5, 407-413.
15. Schneidman-Duhovny, D.; Nussinov, R.; Wolfson, H. Predicting Molecular Interactions in Silico: II. Protein-Protein and Protein-Drug Docking. J. Curr. Med. Chem. 2004, 11, 91-107.
16. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A Fast Flexible Docking Method Using an Incremental Constrution Algorithm. J. Mol. Biol. 1996, 261, 470-489.
17. Ewing, T. J. A.; Kuntz, I. D. Critical Evaluation of Search Algorithms for Automated Molecular Docking and Database Screening. J. Comput. Chem. 1997, 18, 1176-1189.
18. Welch, W.; Ruppert, J.; Jain, A. J. Hammerhead Fast, Fully Autometd Docking for Flexible Ligands to Protein Binding Sites. Chem. Biol. 1996, 3, 449-462.
19. McMartin, C.; Bohacek, R. S. J. Powerful, Rapid Computer Algorithms for Structure-Based Drug Design. J. Comput.-Aided Mol. Des. 1997, 11, 333-344.
20. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E. Belew, R. K.; Olson, A. J. Autometd Docking Using a Lamarkian Genetic Algorithm and an Emperical Free Binding Energy Function. J. Comput. Chem. 1998, 19, 1639-1662.
21. Jones, G.; Willet, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and Validation of a Genetic Algorithm for Flexible Docking. J. Mol. Biol. 1997, 267, 727-748.
22. Totrov, M.; Abagyan, R. Flexible Protein-Ligand Docking by Global Energy Optimization in Internal Coordinates. Proteins 1997, S1, 215-220.
23. Axelsen, P. H.; Harel, M.; Silman, I.; Sussman, J. L. Structure and Dynamics of the Active Site Gorge of Acetylcholinesterase: Synergistic Use of Molecular Dynamics Simulation and X-ray Crystallography. Protein Sci. 1994, 3, 188-197.
24. Taylor, P.; Radic, Z. The Cholinesterases: From Genes to Proteins. Annu. Rev. Pharmacol. Toxicol. 1994, 34, 281-320.
25. Sussman, J. L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Atomic Structure of Acetylcholinesterase From Torpedo californica: A Prototypic Acetylcholine-Binding Protein. Science 1991, 253, 872-879.
26. Pilger, C.; Bartolucci, C.; Lamba, D.; Tropsha, A.: Fels, G. Accurate Prediction of the Bound Conformation of Galanthamine in the Active Site of Torpedo Californica Acetylcholinesterase Using Molecular Docking. J. Mol. Graphics Modell. 2001, 19, 288-296.
27. Linnemann, E.; Pilger, C.; Bartolucci, C.; Lamba, D.; Fels, G. Exploring the Inhibitor Binding-Site of Acetylcholinesterase. In Proceedings of the 9th German-Japanese Workshop on Chem. Information, May, 25-27, 2000; Science and Technology Agency of Japan, NRIM: Saitama, Japan, 2000; pp 87-90.
28. Hardy, J.; Selkoe, D. J. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics. Science 2002, 297, 353-356.
29. Feng, S.; Wang, Z. F.; He, X. C.; Zheng, S. X.; Xia, Y.; Jiang, H. L.; Tang, X. C.; Bai, D. L. Bis-huperzine B: Highly Potent and Selective Acetylcholine Sterase Inhibitors. J. Med. Chem. 2005, 48, 655-657.
30. Greenblatt, H. M.; Guillou, C.; Guenard, D.; Argaman, A.; Boni, S.; Badet, B.; Thal, C.; Silman, I.; Sussman, J. L. The Complex of a Bivalent Derivative of Galanthamine with Torpedo Acetylcholinesterase Displays Drastic Deformation of the Active-Site Gorge: Implications for Structure-Based Drug Design. J. Am. Chem. Soc. 2004, 126, 15405-15411.
31. Luttmann, E.; Linnemann, E.; Fels, G. Galanthamine as Bis-Functional Ligand for the Acetylcholinesterase. J. Mol. Model. 2002, 8, 208-216.
32. Brooijmans, N.; Kuntz, I. D. Molecular Recognition and Docking Algorithms. Annu. Rev. Biophys. Biomol. Struct. 2003, 32, 335-373.
33. Trosset, J.-Y.; Scheraga, H. A. Reaching the Global Minimum in Docking Simulations: A Monte Carlo Energy Minimization Approach Using Bezier Splines. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 8011-8015.
34. Metropolis, N.; Rosenbluth, A. W.; Rosenbluth, M. N.; Teller, A. H.; Teller, E. Equation of State Calculations by Fast Computing Machines. J. Chem. Phys. 1953, 21, 1087-1092.
35. Mezei, M. Efficient Monte Carlo Sampling for Long Molecular Chains Using Local Moves, Tested on a Solvated Lipid Bilayer. J. Chem. Phys. 2003, 118, 3874-3879.
36. Jordis, U.; Froehlich, J.; Treu, M.; Himschall, M.; Czollner, L.; Kaeltz, B.; Welzig, S. European Patent EP 1 181 294 B1.
37. Siotto, M.-C.; Bartolucci, C.; Lamba, D. The crystal structure will be published elsewhere. We thank the authors for providing us with the PDB file prior to publication.
38. Bartolucci, C.; Perola, E.; Pilger, C.; Fels, G.; Lamba, D. Three-Dimensional Structure of a Complex of Galanthamine (Nivalin) with Acetylcholinesterase from Torpedo californica: Implications for the Design of New Anti-Alzheimer Drugs. Proteins 2001, 42, 182-191.
39. Greenblatt, H. M.; Kryger, G.; Lewis, T.; Silman, I.; Sussman, J. L. Structure of Acetylcholinesterase Complexed with (-)-Galanthamine at 2.3 Å Resolution. FEBS Lett. 1999, 463, 321-326.
40. Kryger, G.; Silman, I.; Sussman, J. L. Structure of Acetylcholinesterase Complexed with E2020 (AriceptÂ): Implications for the Design of New Anti-Alzheimer Drugs. Structure 1999, 7, 297-307.
41. Harel, M.; Schalk, I.; Ehert-Sabatie, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L. Quaternary Ligand Binding to Aromatic Residues in the Active-Site Gorge of Acetyl-cholinesterase. Proc. Natl. Acad. Sci U.S.A. 1993, 90, 9031-9035.
42. Hiremath, C. N.; Grant, R. A.; Filman, D. J.; Hogle, J. M. Binding of the Antiviral Drug win51711 to the Sabin Strain of Type-3 Poliovirus - Structural Comparison with Drug-Binding in Rhinovirus-14. Acta Crystallogr., Sect. D 1995, 51, 473-489.
43. Hadfield, A. T.; Oliveira, M. A.; Kim, K. H.; Minor, I.; Kremer, M. J.; Heinz, B. A.; Shepard, D.; Pevear, D. C.; Rueckert, R. R.; Rossman, M. G. Structural Studies on Human Rhinovirus 14 Drug Resistant Compensation Mutants. J. Mol. Biol. 1995, 253, 61-73.
44. Malkowski, M. G.; Ginell, S. L.; Smith, W. L.; Garavito, R. M. The Productive Conformation of Arachidonic Acid Bound to Prostaglandin Synthase. Science 2000, 289, 1933-1937.
45. Stams, T.; Spurlino, J. C.; Smith, D. L.; Wahl, R. C.; Ho, T. F.; Qoronfleh, M. W.; Banks, T. M.; Rubin, B. Structure of Human Neutrophil Collagenase Reveals Large S1′ Specificity Pocket. Nat. Struct. Biol. 1994, 1, 119-123.
46. Champness, J. N.; Bennett, M. S.; Wien, F.; Visse, R.; Summers, W. C.; Herdewijn, P.; de Clercq, E.; Ostrowski, T.; Jarvest, R. L.; Sanderson, M. R. Exploring the Active Site of Herpes Simplex Virus Type-1 Thymidine Kinase by X-ray Crystallography of Complexes with Aciclovir and Other Ligands. Proteins 1998, 32, 350-361.
47. Davis, S. T.; Benson, B. G.; Bramson, H. N.; Chapman, D. E.; Dickerson, S. H.; Dold, K. M.; Eberwin, D. J.; Edelstein, M.; Frye, S. V.; Gampe, R. T.; Griffin, R. J.; Harris, P. A.; Hassell, A. M.; Holmes, W. D.; Hunter, R. N.; Knick, V. B.; Lackey, K.; Lavejoy, B.; Luzzio, M. J.; Murray, D.; Parker, P.; Rocque, W. J.; Shewchuk, L.; Veal, J. M.; Walker, D. H.; Kuyper, L. F. Prevention of Chemotherapy-Induced Alopecia in Rats by Cdk Inhibitors. Science 2001, 291, 134-137.
48. Go, N.; Scheraga, H. A. Calculation of the Conformation of cycloHexaglycyl. 2. Application of a Monte-Carlo Method. Macromolecules 1978, 11, 552-559.
49. Greenblatt, H. M.; Dvir, H.; Silman, I.; Sussman, J. L. Acetylcholinesterase: A Multifaceted Target for Structure-Based Drug Design of Anticholinesterase Agents for the Treatment of Alzheimer's Disease. J. Mol. Neurosci. 2003, 20, 369-384.
50. Silman, I.; Sussman, J. L. Acetylcholinesterase: 'Classical' and 'Non-Classical' Functions and Pharmacology. Curr. Opin. Pharmacol. 2005, 5, 293-302.
51. Bourne, Y.; Taylor, P.; Radie, Z.; Marchot, P. Structural Insights into Ligand Interactions at the Acetylcholinesterase Peripheral Anionic Site. EMBO J. 2003, 22, 1-12.
52. Pang, Y. P.; Kozikowski, A. P. Prediction of the Binding Site of 1-Benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl)piperidine in Acetylcholinesterase by Docking Studies with the SYSDOC Program. J. Comput.-Aided Mol. Des. 1994, 8, 683-693.
53. Cormen, T. H.; Leiserson, C. E.; Rivest, R. L. Introduction to Algorithms; MIT Press: Cambridge, MA, 1990; Chapter 25.24.